Cameron Olezene, M.D. – FDA Inspection, Apr 1, 2026

Record Details

This FDA Inspection record concerns Cameron Olezene, M.D., with an inspection on April 1, 2026, issued by the Philadelphia District Office, covering human drugs.

Company: Cameron Olezene, M.D.
Inspection Date: April 1, 2026
Product Type: Human Drugs
Office: Philadelphia District Office
Person: Anastasia I. Onuorah (Company Rep)

View Company Profile

ID · 15e88a83-6cdf-4712-8702-37375215fcc6

Inspection Facts

Inspection number: 1310560
FDA center: Human Drugs
Project area: Bioresearch Monitoring: Human Drugs
Outcome: Form 483 issued

FDA Citations

21 CFR 312.60FD-1572, protocol compliance
21 CFR 312.66Unanticipated problems

Full citation text and observation details available on the Dashboard.

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Cameron Olezene, M.D.

FDA Inspection

Cameron Olezene, M.D.April 1, 2026